Target intelligence / Profile preview

Tripartite motif-containing protein 21 (TRIM21)

Target
TRIM21
Molecular classification
E3 ubiquitin-protein ligase, TRIM family protein, RING-finger protein, Intracellular Fc receptor
01

Overview

Tripartite motif-containing protein 21 (TRIM21) is a multifunctional cytosolic E3 ubiquitin ligase and a high-affinity intracellular Fc receptor for IgG, IgM, and IgA [1, 2]. It serves as a critical component of the intracellular innate immune system by detecting and neutralizing antibody-coated viruses and bacteria that have escaped extracellular defenses and entered the cytoplasm [2]. Upon binding the Fc region of an antibody, TRIM21 undergoes auto-ubiquitination and recruits the 26S proteasome to rapidly degrade the entire antibody-pathogen complex, a mechanism termed antibody-dependent intracellular neutralization (ADIN) [2, 3]. Additionally, TRIM21 regulates inflammatory signaling by modulating the stability of interferon regulatory factors (IRFs) such as IRF3, IRF5, and IRF7, thereby influencing the production of type I interferons [4]. Clinically, TRIM21 is well-known as the Ro52 autoantigen, with anti-Ro52 antibodies serving as key diagnostic biomarkers for systemic lupus erythematosus and Sjögren's syndrome [1, 5]. In drug development, TRIM21 is the central effector in "Trim-Away" technology, which utilizes exogenous antibodies to trigger the targeted degradation of endogenous proteins, offering a potential therapeutic avenue for diseases driven by "undruggable" proteins [3]. [1] UniProt Consortium. (2023). P19474 (TRIM21_HUMAN). [2] Mallery, D. L., et al. (2010). Antibodies mediate intracellular immunity through tripartite motif-containing protein 21 (TRIM21). PNAS. [3] Clift, D., et al. (2017). A Method for the Acute and Rapid Degradation of Endogenous Proteins. Cell. [4] Espinosa, A., et al. (2009). The Sjögren's syndrome antigen Ro52/TRIM21 regulates T cell function and cytokine production. Journal of Immunology. [5] Schulte-Pelkum, J., et al. (2009). Clinical significance of anti-Ro52 antibodies. Clin Rev Allergy Immunol.

Other names
Ro52SSA1RNF8152 kDa Ro protein52 kDa ribonucleoprotein autoantigen Ro/SS-ASjögren syndrome antigen A1
02

Mechanism of action

TRIM21 is targeted primarily through the recruitment of its E3 ubiquitin ligase activity to degrade specific proteins via antibody-binding (Trim-Away) or through the modulation of its role in interferon signaling and autoantibody recognition.

03

Biological functions

Intracellular antibody-mediated proteolysisUbiquitin-mediated protein degradationInnate immune signaling regulationType I interferon productionPro-inflammatory cytokine regulation
04

Disease associations

Sjögren's syndromeSystemic lupus erythematosusViral infectionCancerInflammatory myopathy
05

Safety considerations

Potential for systemic inflammatory responsesInduction of autoimmunityOff-target degradation of essential proteins in Trim-Away applicationsDysregulation of innate immune signaling
06

Interacting drugs

Antibodies (used in Trim-Away technology)

1 more in the full profile.

07

Biomarkers

Anti-Ro52 autoantibodiesAnti-SSA autoantibodiesTRIM21 mRNA expression levels

Beyond the preview

Go deeper on Tripartite motif-containing protein 21 (TRIM21).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tripartite motif-containing protein 21 (TRIM21).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call